Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
Paydas
Semra
S
D000368:Aged; D047072:Aromatase Inhibitors / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000601:surgery; D005260:Female; D006801:Humans; D000077289:Letrozole; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D015412:Mastectomy, Segmental; D009378:Neoplasms, Multiple Primary / Q000188:drug therapy*; D009570:Nitriles / Q000627:therapeutic use*; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013629:Tamoxifen / Q000627:therapeutic use; D014230:Triazoles / Q000627:therapeutic use*
D047072:Aromatase Inhibitors; D009570:Nitriles; D020845:Selective Estrogen Receptor Modulators; D014230:Triazoles; D013629:Tamoxifen; D000077289:Letrozole